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Joanna C. Sadler, a Jonathan A. Dennis, †ab Nick W. Johnson †a and
Stephen Wallace *a
Interfacing non-enzymatic catalysis with cellular metabolism is emerging as a powerful approach to
produce a range of high value small molecules and polymers. In this review, we highlight recent
examples from this promising young field. Specifically, we discuss demonstrations of living cells
mediating redox processes for biopolymer production, interfacing solar-light driven chemistry with
microbial metabolism, and intra- and extracellular non-enzymatic catalysis to generate high value
molecules. This review highlights the vast potential of this nascent field to bridge the two disciplines of
synthetic chemistry and synthetic biology for a sustainable chemical industry.
1. Introduction
Chemical catalysis is a powerful tool to efficiently access high
value small molecules and materials. Compared to many
biocatalysts, non-enzymatic catalysts offer wide substrate
scope, high turnover numbers, and stability to a wide range
of process conditions. However, chemical syntheses often rely
on fossil fuel-derived starting materials which limits the
long-term sustainability of this approach. Synthetic biology
offers a promising alternative by accessing high value chemi-
cals from low cost renewable or waste feedstocks under
mild conditions.1–3 However, biological pathways are inher-
ently limited by the reactions known to Nature, precluding
access to large areas of chemical space. This has prompted
researchers to explore opportunities in merging these two
traditionally discrete disciplines to benefit from the best of
both worlds.4,5
Through the union of non-enzymatic catalysis and microbial
metabolism, reaction sequences may be accessed that would not
be possible using either technology in isolation (Fig. 1A and B).
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A key article by Wallace and Balskus in 2014 summarised early
contributions and opportunities in this exciting field.4 Therefore,
the purpose of the present article is to summarise progress in this
area in the period 2014–2021. Specifically, the scope will include:
(i) living cell mediated electron transfer processes, (ii) solar-light
driven chemistry interfaced with microbial metabolism and (iii)
intra- and extracellular non-enzymatic catalysis for the production
of high value small molecules. Whilst the field of artificial
metalloenzymes is acknowledged as a promising approach to
widen the scope of synthetic biology, it is not considered to be
‘non-enzymatic’; therefore it falls outside the scope of this review
and instead we direct the reader to recent review articles on the
topic.6–9 Finally, we will outline possible future directions of this
emerging field.
Fig. 1 (A) Synthetic biology blended with synthetic chemistry enables access to larger areas of chemical space than synthetic biology alone. (B)
Biocompatible chemistry involves the use of chemical synthetic tools in a biological synthetic environment. (C) Biocompatible chemistry refers to abiotic
catalysis which is directly interfaced with cellular metabolism, whereas bioorthogonal chemistry does not interact directly with cellular metabolism.
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First, it is important to define the terms ‘biocompatible
chemistry’ and ‘bioorthogonal chemistry’ in the context of this
review. Biocompatible chemistry is defined as non-enzymatic
catalysis interfaced with the metabolism of a living organism.
This may operate in one or more of three ways: non-enzymatic
modification of a microbial metabolite; non-enzymatic genera-
tion of a microbial substrate; or non-enzymatic modification of
a metabolite within a metabolic pathway. In contrast, bioortho-
gonal chemistry is defined as non-enzymatic modification of a
small molecule or biopolymer which occurs independently of
cellular metabolism (Fig. 1C).
2. Living cell mediated redox
processes
2.1. Microbe mediated polymerisation
One of the simplest and most powerful applications of biocom-
patible chemistry is the use of metabolic electrons to catalyse
abiotic reactions. This approach uses membrane-bound
redox proteins found in obligate and facultative anaerobic
microorganisms to drive non-enzymatic reactions at the cell
surface (Fig. 2A). A key example is the use of microbe-initiated
radical polymerisations to produce high value synthetic poly-
mers. Such reactions avoid the use of stoichiometric reductants
and harsh processing conditions typically required for this
chemistry in vitro,10,11 and have the potential to create entirely
new products through the controlled polymerisation of sub-
strates within the architecture of the cell membrane.
Perhaps the most well studied of these is the Gram-negative
anaerobic bacterium Shewanella oneidensis, which possesses
extracellular electron transport (EET) machinery that can use
a variety of molecules and metals as electron acceptors.12–14
This reactivity has recently been harnessed by Fan and
co-workers, who demonstrated the use of S. oneidensis as ‘living
electrodes’ in an atom transfer radical polymerisation (ATRP) of
an oligo(ethylene oxide) methyl ether methacrylate (OEOMA)
monomer under anaerobic conditions.15 Electrons from native
respiratory pathways were able to reduce Cu(II), Fe(II) and Co(II)
catalysts to Cu(I), Fe(I) and Co(I), respectively, which could
then react with a brominated initiator to produce a radical
species and trigger olefin polymerisation (Fig. 2B).15 Further
Fig. 2 Microbe-mediated redox driven polymerisation reactions. (A) Extracellular electron transport proteins mediate redox processes using a wide
range of metals and small molecules as electron acceptors. (B) Microbe mediated atom-transfer radical polymerisation for polymerisation of
oligo(ethylene oxide) methyl ether methacrylate (OEOMA). (C) Controlled reversible addition–fragmentation chain transfer (RAFT) polymerisation of a
oligo(ethylene glycol) methyl ether methacrylate (OEGMA) monomer using E. coli MC4100.
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optimisation highlighted that a Cu(II) tris(2-pyridylmethyl)
amine (TPMA) complex was able to accelerate polymerisation
and improve control of polymer chain length. The membrane-
bound decaheme c-type cytochrome MtrC was found to be an
essential electron donor to Cu(II)-TPMA during the reaction,
with a S. oneidensis DmtrC knockout strain demonstrating
significantly decreased polymerisation rates. In a subsequent
study, the authors demonstrated S. oneidensis mediated radical
polymerisation under aerobic conditions.16 This is a significant
achievement as radical polymerisation reactions are typically
quenched by molecular oxygen. Interestingly, S. oneidensis was
found to rapidly consume dissolved oxygen under poly-
merisation conditions via aerobic respiration, before directing
extracellular electron flux to the metal catalyst at the membrane
to initiate polymerisation. This natural ability to decrease
oxygen levels enabled preparation of various synthetic polymers
under aerobic conditions with comparable yields and chain
lengths to those prepared under anaerobic conditions.16
Radical polymerisation has also been demonstrated using
the metal-reducing Gram-negative bacterium Cupriavidus
metallidurans and the model laboratory bacterium Escherichia
coli.17 Native membrane reductases in both organisms were
able to reduce Fe(III) to Fe(II) to activate a series of radical
initiators for ATRP. Minimal polymerisation was observed in
the absence of live cells, indicating the importance of cellular
metabolism to the catalytic cycle to regenerate active Fe(II).17 It
is noteworthy that polymerisation was also observed with the
Gram-positive anaerobe Clostridium sporogenes, however only
34% conversion was achieved in comparison to 61% and 78%
for C. metallidurans and E. coli, respectively. This was hypothe-
sised to be due to C. sporogenes being less efficient at reducing
Fe(III) than Gram-negative strains. The choice of ligand was also
critical to the success of this reaction, with a balance between
ligand dissociation, microbial toxicity and the overall rate
of polymerisation being necessary to achieve optimum produc-
tivity and polydispersity.15,17 Finally, whilst this system
focusses exclusively on the use and generation of water-
soluble substrates and products, the integration of biphasic
solvents systems or reaction compartmentalisation strategies
could be used to broaden the scope of this approach, including
the polymerisation of metabolic substrates generated from
sustainable feedstocks.
More recently, microbe mediated polymerisation has also
been demonstrated in the absence of a metal catalyst.18 In this
seminal study, Nothling and co-workers demonstrated the
reduction of an aryl diazonium initiator to generate a carbon-
centred aryl radical species using the enteric Gram-negative
pathogen Salmonella enterica serovar Typhimurium TAS2010
and the common laboratory bacterium Escherichia coli MC4100.
This triggered controlled reversible addition–fragmentation
chain transfer (RAFT) polymerisation of an oligo(ethylene
glycol) methyl ether methacrylate (OEGMA) monomer using
the trithiocarbonate chain-transfer agent, TTC-1 (Fig. 2C), with
100% monomer consumption in 24 hours. The reaction was
shown to be initiated by redox-active shuttles in the cell
membrane and facilitated by cellular metabolism. The initiator,
4-bromobenzenediazonium tetrafluoroborate (4-BT), was
shown to be remarkably biocompatible at concentrations
r800 mM, and both strains exhibited stationary phase redox
potentials less than 200 mV (vs. Ag/AgCl) under aerobic and
anaerobic conditions in a variety of growth media. Interest-
ingly, both the cell membrane and intracellular reducing
agents were required for maximum productivity, and the
increased activity of E. coli MC4100 was attributed to favourable
interactions between 4-BT and the cell membrane due to a
decreased lipopolysaccharide (LPS) phenotype. Overall, this
opens up exciting opportunities for laboratory strains of bac-
teria to participate in a wide range of metal-free abiotic poly-
merisation reactions to produce new sustainable materials and
raises the intriguing possibility that diazo-containing natural
products could initiate such reactivity in Nature.18
2.2. Harnessing microbial chemistry for solar light driven
reactions
In addition to use as a source of electrons, microorganisms can
also accept electrons to drive cellular processes. Such systems
are classical examples of microbial syntrophy,19 but more
recently have also used biocompatible reactions to enable
CO2 utilisation in an ongoing drive towards a sustainable,
circular economy.20–22 Work in this field has focussed on
hybrid photosynthesis systems that harness solar energy for
H2 production from water.
23,24 These use non-enzymatic photo-
catalysts which exhibit high solar-to-chemical energy
conversion24 and have shown biocompatibility with various
microorganisms.25 Seminal studies from Torella and co-
workers and Liu and co-workers demonstrated the use of
bioelectrochemical cells containing R. eutropha to produce
PHB and fusal alcohols from CO2 and H2O.
26,27 Using a reactive
oxygen species (ROS)-resistant Co–P alloy cathode, the authors
achieved CO2 reduction efficiencies exceeding that of natural
photosynthesis.26 In a later study, Tremblay and co-workers
interfaced a biocompatible graphitic carbon nitride (g-C3N4)
photocatalyst and catalase-mediated H2O2 degradation with the
facultative autotrophic Gram-negative bacterium Ralstonia
eutropha to produce the biopolymer polyhydroxybutyrate
(PHB) (Fig. 3A). When combined, the photocatalyst formed
large cell membrane-associated aggregates which enabled
charge transfer to intracellular hydrogenases in the presence
of light, increasing H2 and O2 availability to the cell. This
increased PHB titres from CO2 by 2.2-fold and 1.7-fold when
g-C3N4/catalase and CdS nanorods were used, respectively.
28,29
In a related study, the non-enzymatic production of H2 has
been used to support methanogenesis in Methanosarcina
barkeri, an autotrophic archaeon of interest to the biofuel
community. However, current processes are not efficient
enough to be industrially viable.22,30 To address this, Nichols
and co-workers increased methane production by interfacing
the metabolism of M. barkeri with a biocompatible water-
splitting catalyst. The authors developed a two-compartment
biocompatible electrochemical cell using a n-TiO2 photoanode
and p-InP photocathode submerged in a culture of M. barkeri
(Fig. 3B). Using solar energy, the microorganism converted CO2
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and water to methane with high faradaic efficiency (74%) in
minimal media, a 3-fold increase in methane production
compared to unilluminated controls.31
More recently, Ye and co-workers increased methane produc-
tion in M. barkeri using solar energy and a CdS nanoparticle
catalyst (Fig. 3C).32 The authors hypothesised that photoexcita-
tion of CdS would enable electron transfer to membrane-bound
proteins cytochrome b and [NiFe] hydrogenase (Ech) in
M. barkeri.33 After 3 days, a 13-fold increase in methane produc-
tion was observed compared to controls cultured in the absence
of CdS. Transcriptomic experiments showed a 1.5-fold increase
in mRNA copies encoding mcrA within cells cultured in the
electrochemical bioreactor. The mcrA gene encodes the a-sub-
unit of methyl coenzyme M reductase, which catalyses the final
step of methane biosynthesis. This demonstrates that a dynamic
and cooperative interaction exists between the microbe and non-
enzymatic catalyst during the reaction, and suggests that tran-
scriptomic approaches may be used to guide the design of
engineered hosts for new biocompatible reactions in the
future.32 Further studies showed that the photocatalytic perfor-
mance of the catalyst could be enhanced 3.5-fold by doping CdS
with nickel. The authors hypothesised that nickel increases the
stability of the nanoparticle under the reaction conditions,
promoting the transfer of electrons from CdS* to M. barkeri.33
In addition to the generation of H2, Guo and co-workers
recently used photogenerated electrons from InP nanoparticles
to support cofactor regeneration in the yeast Saccharomyces
cerevisiae.34 The knock-out strain S. cerevisiae Dzwf1 was used to
impair NADP+ reduction in the cytosol, which could be rescued
via non-enzymatic photoelectron transfer from InP located at
the cell membrane. Illumination of cells resulted in a 35-fold
increased NADPH-dependent reduction of dehydroshikimic
acid (DHS) to shikimic acid (SA) and this continued for 72 h
to exceed native SA yields from unmodified S. cerevisiae by
3-fold. Although the precise mechanism of electron transport
from InP* to NADP+ is still under investigation, the increased
redox activity of spent reaction cultures after S. cerevisiae Dzwf1
growth suggests the presence of additional redox-active species
in vivo. Together this work highlights the use of biocompatible
chemistry to complement and enhance native metabolic reac-
tions in various microorganisms, and suggests a wider role of
cellular metabolites in non-enzymatic catalysis in the cell
interior.
3. Biocompatible chemistry for small
molecule synthesis
3.1. Intracellular non-enzymatic catalysis
The examples discussed so far harness extracellular or cell
surface mediated electron transfer processes to feed into
microbial metabolism or abiotic polymer synthesis. A comple-
mentary form of biocompatible chemistry is the use of
non-enzymatic catalysis to interface directly with native and
engineered microbial metabolism to access reaction pathways
that would not be accessible using synthetic chemistry or
synthetic biology in isolation. If the catalyst can be generated
by the microorganism or efficiently cross the cell membrane,
this process may occur intracellularly. Whilst examples in this
field are currently limited, there is considerable potential for
this strategy to bridge native enzymatic pathways to enable
new-to-nature metabolic transformations using both transition
metal- and organocatalysis.35
A key example of intracellular biocompatible chemistry is
the use of the Fe(III) complex hemin to bridge two parts of an
engineered biosynthetic pathway for high-yield production of
the industrially valuable compounds diacetyl and (S,S)-2,
3-butanediol by Lactococcus lactis.36 A knockout strain of L.
lactis was generated to inactivate competing pathways and
direct metabolic flux toward a-acetolactate formation. Hemin
then catalysed the biocompatible non-enzymatic oxidative dec-
arboxylation (ALOX) of a-acetolactate to form diacetyl, which
could be reduced to (S,S)-2,3-butanediol by expression of a
heterologous reductase. The bridging of these two path-
ways enabled redox-balanced and growth-coupled (S,S)-2,
3-butanediol production under aerobic conditions (Fig. 4A).
In a subsequent study, Liu and co-workers demonstrated
extension of this system for production of (3S)-acetoin. In this
work, a hemin-catalysed ALOX reaction was used to produce
diacetyl which was coupled with a diacetyl reductase in vivo to
achieve redox balancing and obtain high titres (5.8 g L1) of the
target compound.37
Fig. 3 Biohybrid photosynthesis systems utilising solar-to-chemical
energy conversion. (A) Use of a water-splitting photocatalyst for H2
production to increase PHB production in R. eutropha. (B) Two-
compartment biocompatible electrochemical cell interfaced with a culture
of living M. barkeri for biofuel production. r.e refers to the reference
electrode. (C) CdS mediated photoexcited electron transfer for enhanced
biofuel production in M. barkeri. (D) Biosynthesis of SA from DHS enabled
by in vivo NADPH regeneration mediated by photogenerated electrons
from InP nanoparticles.























































































1078 |  RSC Chem. Biol., 2021, 2, 1073–1083 © 2021 The Author(s). Published by the Royal Society of Chemistry
Beyond ALOX systems, many reported abiotic intracellular
metal-catalysed reactions are examples of bioorthogonal, rather
than biocompatible, chemistry. However, some of these sys-
tems do indirectly influence cellular metabolism, therefore
serving as interesting examples of the interplay between
biocompatible and bioorthogonal reactions in vivo. For exam-
ple, bis[tri(2-furyl)phosphine]PdCl2 encapsulated in poly(lactic-
co-glycolic acid)-b-polyethyleneglycol (‘‘nano-Pd’’) catalyses the
uncaging of allyloxycarbonyl protected prodrugs and can
trigger tumour cell death by release of the active agent, which
interferes with cell replication processes.38 In a second example,
an intracellular bis-allyl Ru(IV)-catalysed redox isomerisation of
allylic alcohols led to the accumulation of a,b-unsaturated
ketones, which deplete intracellular glutathione levels via trap-
ping in a Michael addition reaction.39 In both examples, however,
the key difference from biocompatible systems is that the sub-
strate for non-enzymatic catalysis is exogenous and the product
does not feed into cellular metabolism.
A complementary approach to metal-catalysed biocom-
patible chemistry is interfacing microbial metabolism with
organocatalysis. In 2016, Domaille and co-workers demon-
strated an amino acid-catalysed aldol condensation reaction
that was compatible with E. coli growth conditions.40 A range of
short-chain aldehydes could be converted into the corres-
ponding self-aldol condensation product at room temperature
in bacterial growth media using b-alanine and other biogenic
amines as an organocatalyst. Addition of glyceryl tributyrate
enabled yields of up to 70% and improved cell viability by
alleviating toxicity of the a,b-unsaturated products by in situ
product removal (ISPR). The reaction products are also indust-
rially valuable; the self-aldol condensation product of butanal
dimerization is a key intermediate in the synthesis of 2-ethyl-2-
hexanol, which is currently produced on multimillion-tonne
scale annually using Rh catalysis from fossil fuel derived feed-
stocks. In a subsequent study, Stewart and co-workers showed
that the aldehyde substrate could be produced via the oxidation
of primary alcohols by wild-type Gluconobacter oxydans.41
Coupling this with a lysine organocatalyst at 900 mol% pro-
vided the target a,b-unsaturated products in up to 88% yield
over 24–48 h, redirecting metabolism away from further oxida-
tion of the aldehyde to the carboxylic acid by native dehydro-
genases. A range of cross-aldol products could also be obtained
through addition of other C2–C6 alcohol substrates (Fig. 4B).
Although the precise location of the biocompatible reaction in
E. coli and G. oxydans was not confirmed in either study,
primary alcohol oxidation in G. oxydans is known to occur at
the cytosolic membrane42,43 and amino acid importers are
known in both microorganisms, suggesting that organocataly-
sis could occur in the periplasmic space. However, the absence
of any enhanced rate in the presence of cells due to substrate/
catalyst co-localisation and the high catalyst loading required
for product formation in vivo suggests that organocatalysis, in
this case, likely occurs in the extracellular media after export of
the aldehyde.
This work is an important example of using organocatalysis
for biocompatible chemistry and lays the foundation for future
development of more efficient systems and novel synthetic
pathways. For example, Brewster and co-workers have recently
demonstrated that a,b-unsaturated compounds such as
2-ethylhexenal can undergo enantioselective CQC bond
reduction in the presence of unmodified E. coli.44 Since
bio-based routes to n-butanol are known,45–48 it is therefore
possible to envisage a system for the bio-based synthesis of
2-ethyl-2-hexanol using microbial cell factories.44 Further to
enabling production of high value products under very mild
processing conditions, these studies also illustrate the potential
of unmodified microorganisms to generate substrates for bio-
compatible reactions. Whilst the study of biocompatible chem-
istry inside living cells is still in its infancy, these examples set a
precedent for the development of powerful and elegant
bio-based routes to high value small molecules using low cost
small molecule catalysts.
3.2. Extracellular non-enzymatic catalysis for small molecule
synthesis
Microorganisms have evolved sophisticated mechanisms to
control the entry of abiotic molecules into the cell
interior.49,50 Whilst essential for cell survival in native environ-
ments, this can present as a major challenge when engineering
novel pathways using biocompatible chemistry. Conversely,
using extracellular non-enzymatic catalysis to modify metabolites
obviates the requirement for small molecule catalysts to accumu-
late within the cell. Many metabolites are also excreted from the
cell, such that extracellular modification is preferable for maxi-
mum efficiency. Additionally, modification of metabolites can be
Fig. 4 Intracellular non-enzymatic catalysis for production of high value
small molecules. (A) Fe(II)-catalysed non-enzymatic oxidative decarbox-
ylation (ALOX) of acetolactate in L. lactis enables efficient access to
diacetyl, acetoin and butanediol. DAR refers to diacetyl reductase from
Enterobacter cloacae. (B) Native oxidation of short chain alcohols by
G. oxydans coupled with an organocatalytic aldol condensation gives
access to valuable a,b-unsaturated compounds.























































































© 2021 The Author(s). Published by the Royal Society of Chemistry RSC Chem. Biol., 2021, 2, 1073–1083 |  1079
an effective method of driving flux through a metabolic pathway
towards the product of interest.51 Furthermore, microbes are able
to alter the chemistry of their external environment (e.g. pH and/
or O2 levels
52), potentially facilitating non-enzymatic reactions.
These factors make extracellular non-enzymatic catalysis an
attractive strategy in many biotechnological applications.
A seminal example from Wallace and Balskus in 2016 is the
use of biocompatible vitamin E-derived DL-a-tocopherol poly-
ethylene glycol succinate (TPGS) micelles to interface styrene
production in E. coli with Fe(III)-catalysed cyclopropanation
(Fig. 5A).51 The micelles were shown to associate non-
covalently with the bacterial outer membrane, which was
hypothesised to increase membrane permeability and increase
the rate of styrene removal from the cell cytosol. This ISPR
strategy increased flux through the pathway, leading to a 2-fold
increase in cyclopropane product titres whilst also mitigating
the toxicity of styrene to E. coli. This study was the first example
of micellar catalysis in the presence of a living cell and has
prompted considerable interest in exploring further applica-
tions of biocompatible micelles and ISPR.53–56
In a second example, Gu and co-workers used inverse phase
transfer catalysis to facilitate production of red Monascus pig-
ments (RMPs) from fermentation derived orange Monascus
pigments (OMPs) (Fig. 5B). In their model system, a biphasic
aqueous-tetradecane system was established using a b-cyclo-
dextrin derivative as an inverse phase transfer catalyst (IPTC) to
accelerate the reaction between the lipophilic OMPs and hydro-
philic glutamate.57 Directly interfacing a fermentation of the
mould Monascus aurantiacus with this system enabled product
titres of almost 2 g L1, a 6- and 1.5-fold increase on controls
lacking the IPTC catalyst and tetradecane, respectively. Further-
more, this approach gave high reaction selectivity for RMPs and
very low levels of OMPs and side-products from competing
pathways. These examples demonstrate the potential of
Fig. 5 Extracellular non-enzymatic biocompatible catalysis. (A) Designer micelles increase flux through an engineered styrene pathway from D-glucose
and can be interfaced with iron-catalysed cyclopropanation. (B) Inverse phase transfer catalysis accelerates the reaction between lipophilic OMPs and
hydrophilic glutamate to produce high value OMPs. (C) The ‘GenoChemetics’ platform couples microbial production of non-natural brominated natural
products with extracellular Pd-catalysed cross-coupling to generate abiotic molecules. (D) Generation of high value cycloalkenes via interfacing
biocatalytic decarboxylation of olive oil derived feedstocks with Ru-catalysed ring-closing metathesis. (E) Use of biocompatible micelles to interface a
microbial styrene production pathway from L-Phe with Pd- and Ru-catalysis to generate stilbene and stilbene derivatives.
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compartmentalising microbial metabolites to enable biocom-
patible chemistry to take place.
There have also been notable examples of interfacing micro-
bial metabolism with aqueous phase, extracellular transition
metal catalysis. In 2017, Sharma and co-workers reported a
‘GenoChemetics’ platform in which halide tagged metabolites
could undergo Pd-catalysed Suzuki–Miyaura cross-coupling
in situ to generate non-natural analogues.58 In the first
model system, 7-bromotryptophan produced by an engineered
strain of E. coli was cross-coupled in a one-pot process with
p-tolylboronic acid, whilst a second example demonstrated
production and subsequent cross-coupling of a brominated
derivative of the antibiotic pacidamycin from Streptomyces
coelicolor (Fig. 5C). Further to applications in chemical synth-
esis, this platform may have uses in directed evolution assays
and studying the fate of tagged natural products in biological
systems.58
More recently, Wu and co-workers developed a one-pot
process for the conversion of oleic acid to cycloalkenes, bulk
petrochemicals which are widely used in industrial processes.59
The membrane bound desaturase-like enzyme UndB from
Pseudomonas sp. was found to efficiently catalyse the bis-
decarboxylation of azelaic, sebacic and undecanedioic acids
when heterologously expressed in E. coli. The resultant bis-
alkene products could then undergo biocompatible
Ru-catalysed cyclization via ring-closing metathesis in an aqu-
eous-n-dodecane two-phase system. This enabled access to
cyclopentene, cyclohexene and cycloheptene from olive oil
derived feedstocks, unlocking a new area of chemical space
in the field of synthetic biology (Fig. 5D). In a related study,
Maaskant and co-workers reported use of the biocompatible
micelle strategy to merge microbial styrene production with (i)
Ru-catalysed metathesis and (ii) Pd-catalysed cross-coupling
with a boronic acid.56 For the metathesis reaction, use of an
immobilised Zhan-II Ru catalyst enabled B30% overall conver-
sion from phenylalanine to stilbene via styrene produced by
engineered E. coli. The addition of 0.25% w/v or 2.5% w/v
biocompatible micelles led to 2- or 3-fold increase in styrene
titres, respectively. Interestingly, however, the addition of
micelles did not lead to an increase in stilbene yields, which
was hypothesised to be due to sequestration of styrene by the
hydrophobic immobilisation resin. For the Pd-catalysed cross-
coupling methodology, yields of B30% were obtained via a
two-step process comprising initial production of styrene by
engineered E. coli, followed by addition of the Pd(COD)Cl2
catalyst, micelles and boronic acid. This methodology was
further extended to the cross-coupling of styrene with a panel
of substituted arylboronic acids (Fig. 5E). These studies are
excellent examples of the power of biocompatible chemistry in
enabling overall chemical transformations that would not be
accessible using synthetic biology or synthetic chemistry in
isolation and unlocks exciting possibilities to access new areas
of chemical space from renewable feedstocks.
Extracellular non-enzymatic chemistry has also been demon-
strated with other small molecule catalysts. In 2020, Liu and
co-workers reported a phosphate-catalysed biocompatible
reaction to produce azaphilone alkaloids, a group of fungal
polyketides with applications in drug discovery and as food
colorants.60 Phosphate (added as KH2PO4) was employed as a
Brønsted acid catalyst in the presence of Penicillium sclerotiorum
to enable the one-pot conversion of fermentation-derived azaphi-
lone into the corresponding alkaloid via reaction with a primary
amine. This method enabled rapid access to a library of non-
natural azaphilone alkaloids under very mild conditions and was
also hypothesised to alleviate product inhibition of the polyketide
pathway.60
Finally, it is also noteworthy that a 96-well plate assay has
been developed to rapidly identify biocompatible transition
metal catalysts.61 This system couples biocompatible catalyst
activity with a fluorescence readout via incorporation of an
in situ synthesized non-canonical amino acid into green fluor-
escent protein through Amber stop-codon suppression, a
strategy that has also been used to ‘addict’ E. coli to abiotic
reactions.62 This methodology was hypothesised to be widely
applicable to any chemical transformation that yields a non-
canonical amino acid and therefore presents a general platform
for the identification of new biocompatible reactions in the
future.
4. Conclusions and outlook
This review has highlighted recent examples (2014-present) of
non-enzymatic catalysis interfaced with cellular metabolism to
produce valuable non-natural chemicals and materials. In this
short time, there has been remarkable progress in this young
field, uniting the two traditionally discrete fields of synthetic
chemistry and synthetic biology. Unmodified and engineered
microbes can mediate redox processes for polymer synthesis
and show biocompatibility with solar-light driven photo-
chemical reactions, whilst non-enzymatic catalysts can be
employed both intra- and extracellularly to access new-to-
nature areas of chemical space. In an ongoing drive towards a
more sustainable future, synthetic chemistry reactions are
increasingly being demonstrated in aqueous conditions at
ambient temperatures. In tandem, synthetic biologists con-
tinue to engineer microbes to valorise renewable and waste
feedstocks and show resilience towards harsher processing
conditions. Together with a better understanding of how to
interface chemical and biological systems such as the use of
biocompatible micelles and biphasic systems, we believe that
this field holds exciting potential to deliver sustainable pro-
cesses for the chemical industry.
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